Gilead Sciences Inc. (NASDAQ:GILD) ~ Gilead Sciences: Sovaldi to Boost Shares in 2014, Maxim Group Says

[at Barrons.com] – Maxim Group’s Jason Kolbert upped his target for Gilead Sciences (GILD) today, based on potential sales of Sovaldi. Shares of Gilead gained 104% in 2013, besting Amgen’s (AMGN) 35% rise, . . . → Read More: Gilead Sciences Inc. (NASDAQ:GILD) ~ Gilead Sciences: Sovaldi to Boost Shares in 2014, Maxim Group Says Similar posts: Google Inc. (NASDAQ:GOOG) | ARM shares rise on Google deal report Gilead Sciences Inc. (NASDAQ:GILD) ~ January 2014 Options Now Available For Gilead Sciences (GILD) Gilead Sciences Inc. (NASDAQ:GILD) – New Hepatitis C Drug Success Should Drive Gilead Sciences In 2014
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.